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The transport sector accounts for one of the largest and fastest-growing consumers of energy, and is one of the most diffi-cult to decarbonize. For example, in the United States about 
30% of energy usage is spent on transportation, which currently 
mainly relies on liquid fuels1. Even though there are projections 
of a rapid increase in electric cars, high-power transport vehicles 
(airplanes, ships and long-haul trucks) need high energy-density 
fuels (including high-capacity energy storage, fast energy release 
and rapid charge), and current alternative energy storages (mainly 
batteries) cannot meet this requirement2. A failure to displace the 
fossil fuels used in these heavy vehicles with alternatives would 
result in emissions exceeding the 2 °C COP21 target3. Even though 
it today only accounts for about 3% of GHG emissions, flight-travels 
emission is expected to increase dramatically in the coming years4. 
Furthermore, besides reducing net GHG emissions, bio-based jet 
fuels can be less detrimental to air quality than traditional jet fuel; 
it has been demonstrated that when camelina oil-derived biofuel 
is blended 50:50 (by volume) into traditional jet fuel, particle and 
mass emissions are reduced by 50–70%5.
Currently, biodiesel and bio-kerosene are produced from vegeta-
ble oils, but this production is problematic since it competes against 
use of these oils in the food sector. Furthermore, the yield of oil per 
hectare is very low compared with that of sugar cane, other sugar 
crops and biomass. Thus, the production of bioethanol from sugar 
cane yields 5,000 l ha–1 and 1,000–3,000 l ha–1 from corn, whereas 
production of biodiesel from soybean only yields about 500 l ha–1 
(calculated based on the information from ref. 6). Even though 
processes have been developed for dehydrogenation and cracking 
of non-food plant oils, referred to as hydrogenated esters and fatty 
acids (HEFA) processes, for example, by AltAir Fuels in California 
who is supplying biofuels to United Airlines, these processes will 
suffer from relatively low crop yield. There is therefore a need for 
developing cell factories that can produce hydrocarbons7,8 to be 
used as diesel fuels, as this will allow the use of both conventional 
feedstocks such as corn and sugar cane as well as biomass.
Due to its ease of production and easy blend into gasoline, 
ethanol serves as a good biofuel, but its lower energy content and 
hygroscopicity limits its wider application. Petroleum-derived liq-
uid transportation fuels are hydrocarbons with chain lengths of C5 
to C20 and they posses energy density around 40 MJ kg–1. Among 
these, jet fuels contain aromatic compounds along with linear, 
branched and cyclic paraffins with a chain length of C8–C16, which 
ensure the specific lubricity, freezing point and energy density 
that keep it from boiling, freezing or absorbing water in various 
conditions on land or in the air9. Thus, making similar molecular 
components is necessary for use in the current airline infrastruc-
ture. Current biofuels contain only linear and branched paraffins 
and thus have to be blended with petroleum-derived fuels to ensure 
appropriate properties. For high-level production of hydrocarbons, 
Gevo developed a process for conversion of isobutanol to hydrocar-
bons through condensing its dehydration intermediate isobutene10. 
However, cost-wise it is more attractive to have a direct production 
of hydrocarbons in the bioprocess, and techno-economic analysis 
has shown that even though the mass yield of hydrocarbons from 
glucose is lower than for ethanol, the energy yield can be almost 
the same11. Furthermore, production of hydrocarbons directly by 
fermentation has a better net energy balance than production of 
ethanol11. Projections made by the International Energy Agency 
also state that the total biofuel demand will exceed 30 EJ by 2050 
and that biofuels to be used for trucks and jets may account for more 
than 50% of this12. We will therefore likely see expanded biorefiner-
ies in the future, where plant biomass or natural gas is converted to 
hydrocarbons by microbial cell factories, and thereby provide clean 
and CO2-neutral diesel fuels (Fig. 1).
In this Review, we examine how to address the two major bar-
riers in establishing bioprocesses for hydrocarbon production. 
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Global climate change caused by the accumulation of greenhouse gases (GHGs) has caused concerns regarding the continued 
reliance on fossil fuels as our primary energy source. Hydrocarbons produced from biomass using microbial fermentation pro-
cesses can serve as high-quality liquid transportation fuels and may contribute to a reduction in GHG emissions. Here, we 
discuss the barriers and opportunities for bio-based production of hydrocarbons to be used as diesel and jet fuels and review 
recent advances in engineering microbes for production of these chemicals. There are two main challenges associated with 
establishing bio-based hydrocarbon production from cheap feedstocks; lowering the cost of developing efficient and robust 
microbial cell factories and establishing more efficient routes for biomass hydrolysis to sugars for fermentation. We discuss 
how to develop novel systems and synthetic biology tools that can enable faster and cheaper construction of microbial cell 
factories and thereby address the first challenge, as well as recent advances in biomass processing that will likely lead to 
overcoming the second challenge in the near future.
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First, the efficiency of cell factories producing hydrocarbons 
has to be improved significantly. Current yields that are obtained 
in academic laboratories are typically much lower than the 
theoretical maximum yield11. It is challenging to engineer the 
metabolism of microorganisms and it has been estimated to cost 
in the range of US$50–100 million just to develop the cell fac-
tory for a novel bioprocess13, and this represents a major barrier 
for development of novel bioprocesses, particularly in the 
current regime of relatively low oil prices. However, as discussed 
here developments in synthetic biology and systems biology are 
increasing our knowledge of biosynthetic pathways leading to 
hydrocarbons and how we can rapidly engineer cell factories 
to become more efficient. Second, even though biodiesel and 
bio-kerosene can be produced from corn and sugarcane, it is 
necessary to establish biomass-based processes to ensure suffi-
cient provision of these fuels. Even though there has been much 
research and development towards implementing second-gen-
eration bioethanol production, that is, ethanol production from 
biomass, it is still challenging to integrate microbial fermentation 
processes with biomass hydrolysis processes. We will, however, 
briefly discuss that recent developments suggest that solutions to 
this challenge are likely to be identified within the coming years. 
Finally, we also discuss how alternative single-carbon feedstocks 
and chemical–biological hybrid processes can be explored for 
hydrocarbon production.
Microbial metabolic pathways for hydrocarbon biosynthesis
Hydrocarbon biosynthesis from oxygen-rich sugars present in 
corn, sugar cane and biomass requires extensive chemical reduc-
tion, and there are three naturally evolved reduction extension 
cycles for production of naturally occurring hydrocarbons2: biosyn-
thetic pathways of isoprenoids, fatty acids and polyketides. These 
all rely on acetyl coenzyme A (acetyl-CoA) as a precursor, which 
therefore is a central metabolite for biosynthesis of hydrocarbons 
(Fig. 2 and Table 1).
Hydrocarbon production from the isoprenoid pathway. 
Isoprenoids are naturally produced metabolites with diverse struc-
tures and functions that have wide applications as medicines, 
fragrances and flavours, but some isoprenoids are also very well 
suited as fuels. Isoprenoids are synthesized by condensing five 
carbon units with dimethylallyl diphosphate (DMAPP) as primer 
and isopentenyl diphosphate (IPP) as extending units, which are 
generated via the D-xylulose-5-phosphate (DXP) pathway or the 
mevalonate (MVA) pathway (Fig. 2).
The shortest isoprenoid, isoprene (C5), is an important com-
modity chemical used in a wide range of industrial applications, 
including as a gasoline alternative. Genencor has developed a 
gas-phase bioprocess for isoprene production of 60 g l–1 by engi-
neering the endogenous DXP and heterologous MVA pathways in 
Escherichia coli (E. coli), resulting in a volumetric productivity of 
2 g l–1 h–1 and a yield of 11% isoprene from glucose14. Other microbes, 
such as yeast and cyanobacteria, were also explored for isoprene 
production with much lower titre15,16. Cyanobacteria-based terpene 
production would provide a direct route for fixing of CO2 and solar 
energy by photosynthesis16,17.
Monoterpenes (C10) are considered good candidates for jet 
fuel and biodiesel, since they have desirable properties such as low 
freezing temperature and high ignition stability. Monoterpenes are 
synthesized from geranyl pyrophosphate (GPP) by diverse mono-
terpene synthases. GPP is synthesized by the GPP synthase (GPPS), 
which condenses IPP and DMAPP. E. coli has been extensively 
explored as a cell factory for production of monoterpenes such as 
limonene and sabiene18. With engineering of isoprenoid pathways 
and monoterpene synthase, diverse monoterpenes such as limo-
nene and pinene were overproduced at 0.6–3 g l–1 (Table 1)19–21. 
Yeasts have also been extensively engineered for monoterpene pro-
duction; however, the production is much lower (about 0.02 g l–1) 
than by E. coli22,23. The lower production might be attributed to low 
availability of precursor GPP, since the yeast GPP synthase Erg20 
is a bi-functional enzyme with a higher farnesyl pyrophosphate 
synthase (FPPS) activity consuming GPP, and mutation of Erg20 
enzyme with decreased FPPS activity enabled a 340-fold improve-
ment of sabinene production compared with the original enzyme in 
Saccharomyces cerevisiae (S. cerevisiae)23.
Sesquiterpenes (C15) are another class of molecule of which 
several have excellent properties as biofuels. Amyris, an industrial 
biotechnology company, has developed a yeast cell factory for the 
production of farnesene24, taking advantage of its experience with 
successful engineering of yeast for commercial production of 
artemisinin, an anti-malarial drug. Besides extensive engineering of 
the MVA pathway that is required for artemisinin production25, the 
supply of the precursor acetyl-CoA was improved by constructing 
alternative acetyl-CoA pathways with reduced adenosine triphos-
phate (ATP) consumption, reduced CO2 emission and improved 
redox balance24. Furthermore, an nicotinamide adenine dinucleotide 
(NADH)-consuming 3-hydroxy-3-methyl-glutaryl (HMG)-CoA 
reductase (NADH–HMGR) was introduced to replace the NADPH 
dependent HMGR, which improved the overall cofactor balance. 
The engineered strain with this rewired central metabolism had a 
25% higher farnesene yield from glucose (130 g l–1, 0.173 g per g 
glucose) and 75% less oxygen requirement, which could reduce 
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Fig. 1 | the biorefinery concept for biofuel production from sunlight and 
single-carbon compounds or biomass. Exploiting biological processes for 
production of hydrocarbons by using either biomass produced from CO2 
or direct use of CO2 or CH4. Biomass is synthesized from CO2 and solar 
energy (sunlight) via photosynthesis, and then physical and chemical 
pre-treatment is used to generate 5-and 6-carbon sugars, which can 
subsequently be converted into hydrocarbons by microbial fermentations 
using engineered microbial cell factories. CO2 can also be directly 
condensed to hydrocarbons using an integrated energy supplying module 
(for example, solar energy and electricity) by engineered microbial cell 
factories. Furthermore, microbes can be harnessed for biotransformation  
of other single-carbon molecules such as methanol and methane, which 
can be derived from coal, natural gas and so on.
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the raw material and operational costs. Bisabolane, a fully reduced 
derivative of the sesquiterpene bisabolene, has been shown to be 
a good D2 diesel alternative in terms of physical and chemical 
properties. E. coli and S. cerevisiae were engineered for production 
of bisabolene by selecting the efficient bisabolene synthases and 
engineering the upstream isoprenoid pathway26, which enabled 
production of 900 mg l–1 bisabolene. This study also showed that 
20% (v/v) bisabolene had no negative effect on growth, which indi-
cated that bisabolene has limited toxicity to E. coli and S. cerevisiae, 
enabling further improvement.
Hydrocarbon production from fatty acid biosynthetic pathway. 
Fatty acids are obvious precursors for production of alkanes and 
alkenes27. Fatty acids are biosynthesized by fatty-acid synthase (FAS) 
using acetyl-CoA and malonyl-CoA as building blocks (Fig. 2). 
The products of fatty acid synthase are acyl-acyl carrier protein 
(ACP)/CoA or free fatty acids (FFAs), which can be converted to 
hydrocarbons via two different pathways (Fig. 2): two-step alkane 
biosynthesis where alkanes are synthesized from free or activated 
fatty acids through reduction to fatty aldehydes followed by conver-
sion to alkanes by aldehyde-deformylating oxygenases (ADOs)28,29; 
and one-step 1-alkene biosynthesis directly from free fatty acids by 
different enzymes30–33.
Though some cyanobacteria naturally produce low levels of 
long-chain alkanes, their biosynthetic pathway was only recently 
elucidated28. The reconstruction of the alkane biosynthetic pathway 
from cyanobacteria in E. coli enabled the production of alkanes at 
0.3 g l–1, which were mainly mixtures of C13, C15 and C17 (ref. 28). 
To obtain gasoline-like alkanes, the E. coli fatty acid metabolism 
was engineered for short-chain fatty acid production followed by 
reconstruction of an alkane pathway, which enabled the production 
of short-chain alkanes at 580 mg l–1 (ref. 34). E. coli has also been 
engineered for production of propane at 32 mg l–1 by manipulating 
fatty acid synthesis for supply of the precursor butyrate35. Recently, 
modular engineering of the β -oxidation operating in a reverse 
direction enabled the biosynthesis of short-chain alkanes (propane, 
butane and pentane)36.
The low alkane biosynthesis in microbes is mainly attributed to 
poor catalytic activity of ADOs37 and strong competition of aldehyde 
reductases and alcohol dehydrogenases (ALR/ADHs)38. To increase 
the ADO activity and relieve ALR/ADH competition, protein fusion 
and scaffolding were applied to improve the channelling of substrate 
fatty aldehyde between AAR and ADO, which enabled two to eight 
times higher alkane production39,40. Furthermore, balancing the 
alkane biosynthesis, fatty alcohol accumulation and fatty acid metab-
olism and engineering the electron transfer system significantly 
improved alkane production to 1.31 g l–1 in E. coli under fed-batch 
fermentation, the highest reported titre in engineered microbes41.
1-Alkenes (olefins) can be produced directly from FFAs through 
expression of the fatty acid peroxygenase OleTJE in a fatty acid-
overproducing E. coli strain, leading to production of 97 mg l–1 long 
odd-chain 1-alkenes42 with a chain length of C13–C17. Recently, 
a non-heme iron oxidase was identified to enable medium-chain 
1-alkene production in E. coli with a titre of 5 mg l–1 (ref. 31), while 
desaturase-like UndB was shown to be more efficient for produc-
tion of 1-alkenes (60 mg l–1) with a broad product spectrum of 
C7–C17 in E. coli30.
S. cerevisiae is widely used as a cell factory due to its robust-
ness toward harsh industrial conditions. The first demonstration of 
alkane production by yeast was a reconstruction of very long-chain 
alkane (mainly C29 nonacosane) biosynthesis from Arabidopsis 
thaliana (A. thaliana)29. More recently, the cyanobacteria alkane 
pathway was successfully reconstructed in S. cerevisiae, follow ing the 
identification of the main competing enzyme, aldehyde dehydro-
genase Hfd1. Deletion of hfd1 in combination with expression of 
E. coli ferredoxin and ferredoxin-NADP reductase allowed the 
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Fig. 2 | Metabolic pathways for production of hydrocarbons in microorganisms. Single-carbon feedstocks are condensed to the common precursors 
pyruvate or acetyl-CoA while biomass derived sugars are catabolized to precursors in central metabolism, and the precursors are used as building blocks 
for biosynthesis of chain-extended intermediates by isoprenoid, fatty acid or polyketide biosynthetic pathways. Downstream tailored pathways transform 
intermediates to hydrocarbons that can be used directly as drop-in biofuels. G3P, glyceraldehyde 3-phosphate; MEP, methylerythritol 4-phosphate; 
MVA, mevalonate; DMAPP, dimethylallyl diphosphate; IPP, isopentenyl diphosphate; GPP, geranyl diphosphate; FPP, farnesyl diphosphate. The polyketide 
synthase contains multiple domains (shown in a box): KS, β-keto-synthase; AT, acyl-transferase; ACP, acyl carrier protein; KR, β-keto-reductase;  
DH, dehydratase; PPT, phosphopantetheinyl transferase. TE, a cognate thioesterase that is separately expressed.
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production of alkanes at 0.1 mg l–1 (ref. 43). Construction of a FFA-
derived alkane pathway resulted in almost 300% improved alkane 
production compared to the fatty-CoA derived pathway44. Deletion 
of the main ALR/ADH adh5 and enhancement of the expression of 
ADO further increased alkane production by 70%, again pointing 
to this step as having major flux control44. As an alternative strategy, 
the alkane pathway was targeted to the peroxisome, an organelle 
responsible for FFA degradation and free of ALR/ADHs, which 
improved alkane production by 100% with decreased accumula-
tion of by-product fatty alcohols. Engineering peroxisome biogen-
esis further enhanced alkane production by threefold (3.6 mg l–1)45. 
OleTJE catalysed 1-alkene production is low in S. cerevisiae, that is, 
3.7 mg l–1 1-alkenes under fed-batch fermentation46 compared with 
97 mg l–1 in E. coli, but production of olefins could also be improved 
by targeting the pathway to the peroxisomes45. Furthermore, 
dynamic expression of a desaturase-like UndB and exporter long-
chain fatty acid transport protein 1 (FATP1) in a FFA overproduc-
ing S. cerevisiae resulted in the production of 35.3 mg l–1 1-alkenes 
with more than 80% being secreted, which represented a tenfold 
improvement compared with earlier reported 1-alkene production 
by S. cerevisiae47. Recently, the yeast type-I FAS domain, which pre-
viously was considered to be rigidly organized, has been engineered 
for biosynthesis of short-chain fatty acids and their derived hydro-
carbons48–50. This opened a door to explore FAS I novel functions for 
production of new hydrocarbons with different properties.
Expression of a soybean lipoxygenase (Gmlox1) in the oleagi-
nous yeast Yarrowia lipolytica (Y. lipolytica) transformed inoleic acid 
into tridecadieonoic acid and pentane at a titre of 5 mg l–1 (ref. 51). 
However, this lipoxygenase-based pathway has high substrate speci-
ficity towards linoleic acid, a rare fatty acid species, and would pro-
duce equal molar of by-product tridecadieonoic acid, which limits 
its future industrial application. Recently, reconstruction and opti-
mization of alkane biosynthetic pathways in Y. lipolytica enabled 
alkane production of 23 mg l–1 (ref. 52). The relatively low alkane 
titre in yeast compared with bacteria (Table 1) might be attributed 
to the unsuitable environment for ADO activity in the yeast cytosol. 
ADOs are iron and ferredoxin-dependent, and iron–sulfur clusters 
are assembled in the mitochondria of yeast and the yeast iron–sul-
fur clusters may also be incompatible with ADOs of bacterial origin.
Cyanobacteria can produce alkanes directly from CO2 and sun-
light53, but the low productivity limits industrial application. Many 
cyanobacteria naturally produce polyhydroxybutyrates (PHB) that 
are also derived from acetyl-CoA, and by expressing alkane path-
way genes carbon flux was redirected to acyl-ACP by blocking PHB 
biosynthesis, resulting in 8.3-fold improved alkane production 
(26 mg l–1)54.
Hydrocarbon production from polyketide biosynthetic path-
ways. Polyketides represent a family of natural products that pos-
sess a wide variety of pharmacological or biological activities, and 
the type-I polyketide synthase (PKS1) is very similar to FAS with 
multiple domains, which can be used for reductive biosynthesis of 
hydrocarbons. A polyketide synthase Ols from Synechococcus has 
been verified to be involved in biosynthesis of 1-alkene 1-non-
adecene33. Recently, an iterative type-I polyketide synthase (PKS) 
SgcE, which is involved in enediyne core biosynthesis, has been 
engineered for production of pentadecaheptaene. Optimizing the 
expression of SgcE and its cognate thioesterase (TE) SgcE10 in 
Table 1 | Microbial production of hydrocarbons
Hydrocarbon products Chain length Host Cultivation conditiona titre Yield ref.
Isoprenoid derived
Isoprene C5 E. coli MM + glucose, fed-batch 60 g l–1 0.110 g per g 14
Isoprene C5 S. cerevisiae MM + sucrose, fed-batch 2.5 g l–1 0.011 g per gb 15
Isoprene C5 S. elongatus BG-11 medium + CO2 flow 1.3 g l–1 65% fixed carbon 16
Limonene C10 E. coli EZ rich media + glucose, shake flask 605 mg l–1 0.061 g per g 21
Limonene C10 Y. lipolytica CM + glucose, shake flask 24 mg l–1 NCc 22
Limonene C10 Synechococcus sp Solid A + media with N depletion 4.5 mg l–1 NCd 17
Sabinene C10 E. coli MM + glycerol, fed-batch 2.7 g l–1 3.5 × 10–3 g per g 20
Farnesene C15 S. cerevisiae MM + glucose, fed-batch 130 g l–1 0.173 g per g 24
Bisabolene C15 E. coli EZ rich media + glucose, shake flask 1.15 g l–1 0.015 g per g 21
Bisabolene C15 S. cerevisiae CM + galactose + glucose, shake flask 1.0 g l–1 0.05 g per g 26
Fatty acid derived
Long-chain alkanes C13–C17 E. coli MM + glucose, shake flask 0.30 g l–1 0.010 g per g 28
Long-chain alkanes C15, C17 E. coli MM + glycerol, fed-batch 1.31 g l–1 0.011 g per g 41
Short-chain alkanes C9–C13 E. coli MM + glucose, shake flask 0.58 g l–1 NCc 34
Short-chain alkanes C3, C4, C5 E. coli LB + glycerol, shake flask 1.3–4.3 mg l–1 NCc 36
Propane C3 E. coli MM + glucose, batch 32 mg l–1 4.3 × 10–4 g per g 35
Long-chain alkanes C13–C17 S. cerevisiae MM + glucose, shake flask 3.6 mg l–1 1.2 × 10–4 g per g 45
Long-chain alkane C13–C17 Y. lipolytica MM + glucose, shake flask 23 mg l–1 3.9 × 10–4 g per g 52
Long-chain 1-alkenes C13–C17 E. coli MM + glucose, shake flask 97 mg l–1 3.2 × 10–3 g per g 42
Long-chain 1-alkenes C11–C19 S. cerevisiae MM + glucose, shake flask 35.3 mg l–1 1.8 × 10–3 g per g 47
PKS derived
Pentadecaheptaene C15 E. coli MM + glucose, fed-batch 140 mg l–1 0.003 g per g 55
aMM, minimal media; SMM, semi-minimal media containing complex media component such as yeast extract; CM, complex media. bThis yield was estimated based on the OD600, with 1 OD600 cell 
density is 0.6 g DCW l–1 and a biomass yield of 0.5 g DCW per g glucose. cNot calculated due to containing complex media component such as yeast extract. dNot calculated due to a lack of information on 
consumption of carbon sources such as glucose.
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E. coli resulted in high pentadecaheptaene production, while fed-
batch fermentation followed by chemical hydrogenation resulted 
in 140 mg l–1 pentadecane55. Furthermore, hybrid PKSs have been 
constructed from different naturally occurring PKS and expressed 
in E. coli, which enabled the production of a variety of α -olefins 
such as propene, pentene and 1-hexane56. These results clearly show 
the potential of engineering PKS for production of hydrocarbons 
with different chemical structures, by exploiting the high flexibility 
of PKS modules57.
The challenge of hydrocarbon toxicity and possible solutions. 
Hydrocarbons, especially many terpenes, cause toxicity stress to 
microbial cells58, which limits the improvement of titres and pro-
ductivities. Transporter and tolerance engineering has successfully 
improved the robustness of microbial cell factories; however, cellu-
lar energy is required to relieve this stress and thus lower yields are 
obtained59. In contrast to the focus on bioactivity in pharmaceuti-
cal use, for hydrocarbons to be used as biofuels the thermodynamic 
and physicochemical properties are more important and these must 
be comparable to current fuels. Thus, identifying non-toxic or low-
toxicity hydrocarbons, with similar properties to current petro-
leum-derived fuels, would be a feasible approach to realize high 
production without product inhibition (Fig. 3). Since terpene struc-
tures are controlled by terpene synthases, construction of a library 
of terpene synthase genes in microbial cells followed by growth-
coupled screening could enable identification of non- or low-toxic 
molecules for further pathway and robustness engineering. With 
construction of multiple pathways that can operate in parallel, it is 
possible to create cell factories that produce a terpene mix with sim-
ilar thermodynamic and physicochemical properties to petroleum-
derived fuels. For example, it was found that a farnesene-overlay 
in a limonene producing cell culture for in situ product extraction 
relieved limonene toxicity significantly, and a 10% (v/v %) blend 
of limonene in farnesene had similar physicochemical properties to 
Jet-A specifications60. Thus, precise metabolic engineering would 
enable cell factories to produce a mix of limonene and farnesene 
at a ratio of 10:90 (by volume) that can be used as Jet-A fuels with 
less toxicity compared to single limonene producing cells, which is 
beneficial for higher biosynthetic efficiency (Fig. 3).
Engineering utilization of single-carbon feedstocks
Single-carbon feedstocks for hydrocarbon production have the 
advantage of high natural abundance (for example CO2 and methane) 
or current large-scale manufacturing (for example methanol, which 
is produced from natural gas or coal). The use of CO2 as a carbon 
source could also directly reduce GHG emissions, while methane, 
a major component of natural gas and also a GHG, can addition-
ally be used as a feedstock for bio-manufacturing of chemicals 
and biofuels61. Methanol, which is produced in very large amounts 
from natural gas or coal, also represents a usable carbon source for 
microbial fermentations62.
CO2 itself can be used as the main carbon source for biomass 
and energy storage through natural photosynthesis, but the rate of 
natural photosynthesis is low and therefore efficiency is not suffi-
cient for commercial production. Furthermore, it does not result in 
chemicals that can be used as fuels. Compared to biomass-derived 
sugar biomanufacturing, it is more challenging to produce hydrocar-
bons (for example, farnesene) from CO2, since it requires extensive 
chemical reduction and thus needs large amounts of reducing power 
to remove oxygen atoms and supply the hydrogen atoms (Fig. 4). 
Most attempts to improve biological CO2 fixation have focused on 
engineering the photosynthesis efficiency in natural systems63,64. 
However, the slow growth and difficulty with engineering plants 
and autotrophic organisms limits the progress in improving the 
native CO2 fixation efficiency for production of specific chemicals. 
Alternative efforts have focused on engineering CO2 fixation sys-
tems into cell factories like E. coli and S. cerevisiae65,66. Recently, 
a chimeric functional Calvin–Benson–Bassham cycle was intro-
duced into E. coli, which enabled the biosynthesis of sugars and 
other major biomass constituents with the energy module for ATP 
and reducing power supply67. This study achieved a fully functional 
non-native carbon assimilation cycle to synthesize pathway inter-
mediates and products from CO2 in a heterologous host, which 
represents an important advance toward the goal of engineering 
autotrophy into a model microorganism. In another study, a non-
natural CO2 fixation cycle, the ‘crotonyl–CoA/ethylmalonyl-CoA/
hydroxybutyryl-CoA’ (CETCH) cycle, was more energy efficient 
and achieved unprecedented in vitro CO2 fixation efficiencies68. 
The energy harvest efficiency in photosynthesis is, however, rel-
atively low, and therefore alternative approaches have been used 
such as combining inorganic semiconductors for more efficient 
energy harvesting and using the non-photosynthetic bacterium 
Moorella thermoacetica to capture electrons from the semicon-
ductors and fix CO2, enabling production of acetic acid from CO2  
(ref. 69). A similar concept allows for use of electrons from electric-
ity, for example, generated by wind, solar or hydro, for conversion 
of CO2 to chemicals that can be used as fuels, for example, isobu-
tanol70. Artificial photosynthesis could also play an important role 
in developing efficient and elegant processes for solar-hydrocarbon 
conversion through CO2 fixation71.
Is
op
re
no
id
 p
at
hw
ay
Is
op
re
no
id
 p
at
hw
ay
 
Terpene
synthases
Microbial cells Robust microbial cells
Terpene
synthases
Library construction Growth-coupled screening Metabolic engineering High-quality biofuel
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NaturE ENErgY | VOL 3 | NOVEMBER 2018 | 925–935 | www.nature.com/natureenergy 929
Review ARticle NaTure eNerGy
Methane is a main component of natural gas and accounts for 
another main source of GHG emissions besides CO2. Thus, explor-
ing methane as a feedstock for biomanufacturing61 could relieve 
substrate stress and GHG emissions. Methane catabolism is initi-
ated by oxidized activation via methanol. It should be mentioned 
that methane/methanol have higher hydrogen/oxygen ratios than 
sugar and CO2, which make them thermodynamically well suited 
for hydrocarbon biosynthesis (Fig. 4). Thus, converting methane 
and methanol to hydrocarbon-based biofuels could contribute 
to the production of transportation fuels in addition to their use 
in other sectors72. With the rise in shale gas production there has 
been increased interest in using methanol as a carbon source for 
bioprocessing. There are two different approaches for engineering 
microorganisms for conversion of methanol to hydrocarbons: (1) 
engineering methylotrophy into non-methylotrophic hosts such 
as E. coli or S. cerevisiae, which has been successfully exploited for 
the overproduction of a variety of products (top-down pipeline)73; 
(2) construction and optimization of heterologous downstream 
biosynthesis pathways for overproduction in a methylotrophic host 
(bottom-up pipeline)62 (Fig. 5). Establishing synthetic methylo-
trophy (approach 1), that is, reconstruction of the methanol utili-
zation pathway in a clean chassis host, can give insight into the 
methanol catabolism mechanisms, which can help to improve the 
methanol conversion efficiency in natural methylotrophic hosts. 
For example, construction and optimization of a methanol utiliza-
tion pathway from methylotrophic bacteria in E. coli enabled the 
incorporation of methanol into central metabolites74 and even spe-
cific chemicals such as naringenin75. Unfortunately, the synthetic 
strain could not grow on methanol as the sole carbon source, and 
the methanol catabolism efficiency is still too low for industrial 
application. However, engineering of a methylotroph pathway into a 
non-methylotrophic chassis gives important insights into methanol 
catabolism. Alternatively, engineering of the methylotrophic bac-
terium Methylobacterium extorquens enabled de novo synthesis of 
the sesquiterpene α -humulene (1.65 g l–1) from methanol (Fig. 5b)76. 
Through further optimization of the methanol utilization and iso-
prenoid pathways, production of mevalonate reached 2.7 g l–1 with 
a yield of 0.08 g per g methanol77. The methylotrophic yeast Pichia 
pastoris has also been engineered for production of lycopene78 
and nootkatone79. These results show the potential in engineering 
methylotrophic microorganisms for production of hydrocarbons 
from methanol, which could be used for conversion of natural gas 
or coal to hydrocarbons (Fig. 1). This approach could pave the road 
for conversion of coal to microbial-derived hydrocarbons that rep-
resents a cleaner route to energy supply than burning coal directly.
It is more challenging to use methane directly because methane 
activation (that is, partial oxidation) is extremely inefficient, and this 
poses a considerable upstream problem in the biological production 
of fuels or chemicals from methane80,81. There are two main biologi-
cal methane oxidation routes: aerobic methane oxidation catalysed 
by methane monooxygenase, and the much less efficient anaerobic 
oxidation mainly catalysed by methyl-coenzyme M reductase. The 
current methane bioconversion primarily focuses on engineering 
methanotrophs that use the methane oxidation route for produc-
tion of chemicals and biofuels82. Methanotrophic bacteria have been 
engineered for production of several biofuel molecules (isobutanol, 
butanol, fatty alcohols and fatty acid methyl esters)83 and farnesene84 
by using methane as a carbon source, but in all cases with a very low 
titre. There are fewer reports on using anaerobic methane oxida-
tion, but the archaeal methanogen Methanosarcina acetivorans has 
been engineered to grow on methane and anaerobically convert it 
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Methylotrophic pathways must be engineered to enable methanol 
utilization in non-methylotrophic microorganisms such as E. coli or S. 
cerevisiae. Well-developed molecular techniques and an extensive library 
of knowledge in model microbes enables rapid metabolic engineering for 
production of specific compounds such as isoprenoids and fatty acid-
derived hydrocarbons from intermediate acetyl-CoA. b, This approach 
requires engineering of downstream hydrocarbon biosynthesis pathways 
in methylotrophic organisms, which have relatively high methanol 
catabolism. Reconstruction and optimization of downstream tailoring 
pathways redirect the metabolic flux toward hydrocarbon biosynthesis 
from methanol. However, the limited availability of genetic tools and 
biochemical knowledge makes it more difficult to perform pathway and 
cellular engineering. The arrow width indicates the strength of metabolic 
flux; the purple and pink dots represent the intermediates of methyltrophic 
pathways and downstream pathways, respectively.
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into acetate85, which is assumed to be more energy efficient than 
the aerobic methane oxidation. So far there has been no success-
ful report on engineering methanotrophy into model organisms 
such as E. coli or S. cerevisiae, and only the soluble domain of the 
β -subunit methane oxygenase has been expressed in E. coli with 
extremely low activity86, clearly demonstrating the challenge in con-
structing a non-natural methanotrophic host for methane conver-
sion. Besides the challenge of improving the efficiency of methane 
activation, development of methane-based biomanufacturing faces 
two other major challenges: the first challenge is the low solubility of 
methane and oxygen that limits the gas-to-liquid (GTL) mass trans-
fer and impacts the productivity of the fermentation process. Thus, 
it is necessary to improve the mass transfer of oxygen and methane 
and recycle the residual gas with new bioreactor design, which has 
been widely explored in the chemical industry such as slurry reactor 
design. GTL mass transfer efficiency can be enhanced by increasing 
the gas solubility via pressurizing the bioreactor or by increasing the 
GTL mass-transfer coefficient (kLa) via improving the bioreactor 
design. As an example, a bubble column bioreactor was optimized 
for anaerobic CO2 fixation with the acetogenic bacterium Moorella 
thermoacetica87, which enabled efficient acetic acid production from 
CO2 at a titre of 31 g l–1, and a productivity of 0.55 g l–1 h–1. A second 
challenge is improving the robustness of the methanotrophic hosts 
to ensure that they have high growth rates and are resistant to indus-
trial conditions. Methanotrophic microbes live at a low density in 
natural conditions, which are not suitable for industrial processes, 
and it is therefore necessary to engineer these organisms to have 
higher growth rate and improved tolerance against harsh industrial 
conditions to ensure high productivities.
Challenges and solutions
As mentioned earlier, there are two major barriers in developing 
bio-based production of hydrocarbons. The first is the realization 
of an efficient and robust cell factory11, and the development of 
an industrially relevant cell factory is a costly process, typically 
US$50–100 million and involves several different steps13 (Fig. 6). 
The second is in developing efficient integration of microbial con-
version of sugars to hydrocarbons with a process for biomass hydro-
lysis, used to produce the sugars.
Proof-of-concept cell factory. Cell factory development com-
mences with a proof-of-concept, initiated by identifying a hydro-
carbon of interest and existence of a naturally occurring biosynthetic 
pathway. While natural producers can occasionally be found, for 
example, alkane-producing cyanobacteria28, these species often pre-
clude further optimization and eventual industrial use due to very 
low productivity or poor robustness towards harsh industrial condi-
tions. Alternatively, a strategy can be designed where the pathway 
is expressed in a heterologous host with more beneficial character-
istics and that is genetically tractable, for example, the transfer of 
A. thaliana genes to S. cerevisiae for alkane production29. The dis-
covery of efficient enzymes from nature is challenging and could 
benefit from high-throughput screening of enzymes from a wide 
range of backgrounds.
Improving titre, rate and yield. While a proof-of-concept dem-
onstrates feasibility of hydrocarbon production, it is merely the 
onset for extensive improvement towards an industrial microbial 
cell factory. Three key metrics for a successful bioprocess are titre, 
rate and yield (TRY) (Figs. 6 and 7). Many academic studies only 
report final titre as a measure of performance, as illustrated in our 
review of different engineered strains above. However, due to the 
relatively low cost of hydrocarbons, the most important metrics 
to optimize are arguably rate and yield: high rate (or productivity) 
requires less capital investment while high yields ensure efficient 
utilization of the feedstock, which may account for up to 70% of 
total production costs (the case for bioethanol production) but may 
be lower if biomass is used as feedstock. Titre, cannot, however, be 
disregarded, as a dilute mixture of hydrocarbons increases costs in 
downstream processing. Current yields (Table 1) leave plenty of 
room for improvement, as the theoretical maximum yield of many 
biofuels is around 0.3 g per g glucose (Fig. 7). Even at maximum 
theoretical yield, economic evaluation of biofuel production indi-
cates the need for subsidies to compete directly with oil. Assuming 
a FA ethyl ester production rate of 7.5 g l–1 h–1 and an annual pro-
duction up to 75,000 tons, the sugar price should be below US$0.07 
for a biodiesel price of US$0.60 per litre11, but sugar is currently 
priced above US$0.20 kg–1. A mature lignocellulose process may be 
able to produce sugar at around US$0.08 kg–1 (ref. 88), while alterna-
tive sources can potentially provide carbons more cheaply, possibly 
allowing cost-competitive biofuel production in the future.
The TRY metrics can be improved by metabolic engineering of 
the cell factory, for example, expressing heterologous genes or modu-
lating the expression of autologous genes13. This engineering is, how-
ever, troubled by the rigidity of microbial metabolism: millions of 
years of evolution have shaped microbial metabolism to efficiently 
produce the building blocks and energy that microbes require for 
their growth. Redirecting carbon and energy flux towards a desired 
hydrocarbon can therefore be challenging, and thus much interest 
exists in developing platform cell factories that are optimized for 
high-level production of specific precursors89. For hydrocarbons in 
particular, platform strains optimized for acetyl-CoA production 
are of interest, as many hydrocarbons have acetyl-CoA as a precur-
sor90. Another consideration is the use of a host that naturally has 
a considerable carbon flux towards production of precursors or 
similar molecules as the hydrocarbon of interest91. Oleaginous yeast 
such as Y. lipolytica are capable of accumulating large amounts of 
lipids that can be converted to preferred hydrocarbons52. In addition 
to optimizing biosynthetic pathways, catabolic pathways require 
attention, for example, for a biorefinery where biomass is used as 
feedstock, cell factories should be capable of efficiently metaboliz-
ing both C5- and C6-sugars. Therefore, already in an early stage it 
should be decided what feedstock will be used and this should be 
taken into consideration when choosing the cell factory.
Improving TRY metrics typically involves iterative rounds of 
the ‘Design-Build-Test-Learn (DBTL)’ cycle13 (Fig. 6). During the 
design (D) phase, the researcher has an objective in mind, such 
as increased productivity of a hydrocarbon. These objectives can 
be obtained via various strategies, such as changing co-factor 
preferences of pathway enzymes, removing competing pathways, or 
screening of efficient alternative biosynthetic pathways or enzymes. 
Designing new strategies can be aided by computational analysis, 
where genome-scale metabolic models (GEMs) in particular 
have been shown to be helpful92. GEMs can be used to in silico test 
different engineering strategies, prioritizing designs predicted to 
have the most beneficial effects93.
Once a new design has been enumerated, implementation takes 
place during the build (B) phase. This challenging phase is not only 
aided using platform strains, but also advances in gene synthesis 
and CRISPR–Cas9 technology for genome editing have significantly 
shortened the build phase. Moreover, high-throughput robotics is 
now capable of building many strains in a short period.
Newly built cell factories are subsequently tested (T), not only 
focusing on the design objective, or even merely quantifying the TRY 
metrics, but also including study of the strain physiology and regula-
tory response using omics analysis94. Such a systems approach allows 
broader questions to be answered: if a competing pathway is blocked, 
or a new pathway is introduced, how does the cell factory redirect 
its fluxes and respond by altering gene expression? The microbe’s 
response can be measured on various levels, using techniques such 
as metabolomics, proteomics and transcriptomics. This information 
results in new knowledge about the cell factory and represents the 
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learn (L) phase, which can be used to guide the next design round. 
The L phase is of particular importance when a design fails, that is, 
the design objective was not met, as through understanding the fail-
ure new knowledge about the cell factory is acquired.
The DBTL cycle represents a stepwise improvement towards 
producing an industrial cell factory, a process that is expensive and 
takes many years as it involves many rounds of the DBTL cycle.
Robustness and scale-up. A desired property of cell factories 
important to consider is their ability to tolerate harsh industrial 
conditions, for example, high osmolarity, hypoxia and in parti-
cular high product concentrations. As part of the scale-up from 
laboratory-scale to industrial-scale fermentations, the cell factory’s 
robustness can be improved through adaptive laboratory evolu-
tion where the microbe is evolved to withstand harsh conditions95. 
Due to random mutations naturally occurring during the cell 
cycle, prolonged exposure to harsh conditions eventually results 
in beneficial mutations that confer an advantage for the cell. This 
approach has been used to identify how S. cerevisiae can be engi-
neered to tolerant high temperatures96 and low pH97, while in both 
cases mutations in ergosterol biosynthesis conferred tolerance 
by altering membrane sterol compositions. Another detrimental 
source of inhibition is contamination of the feedstock with inhib-
iting compounds. This is of particular concern with biomass as it 
requires harsh pre-treatment to release the fermentable sugars. To 
this end, E. coli has been evolved to withstand increasing levels 
of ionic liquids that are used in lignocellulosic hydrolysis, but the 
underlying mechanism was not elucidated98.
Moving to the use of biomass as a feedstock. Today, primarily 
corn and sugar cane are being used as feedstock for production of 
microbial-derived biofuels, but there have been several initiatives to 
use lignocellulose from biomass, for example, corn stover, wood or 
bagasse, as an alternative feedstock. Due to its abundance, biomass 
is considered as an ideal bio-refinery feedstock for production of 
hydrocarbon-based biofuels, and clearly it will be necessary to even-
tually integrate a microbial fermentation process for conversion of 
sugars to hydrocarbons with a process for deconstruction of bio-
mass to fermentable sugars. This deconstruction process generally 
starts with a pre-treatment process followed by enzymatic hydroly-
sis. Various pre-treatment processes have been developed, that is, 
physical, chemical, biological or a combination of these99, and some 
of these have even been implemented for large-scale processing of 
biomass in connection with second-generation ethanol production. 
One example is the Beta Renewables plant in Crescentino, Italy, that 
uses rice and wheat straws as biomass feedstock to produce about 
40,000 tons of ethanol annually. In the pre-treatment stage biomass 
breaks into pulp at the microscopic level resulting in separation into 
lignin, cellulose and hemicellulose. The different fractions can then 
be further processed, and using enzymatic degradation combined 
with fermentation, so-called simultaneous saccharification and 
fermentation, the production costs has been reduced significantly. 
A similar process has been implemented by SEKAB in Sweden, in 
this case for processing of wood chips and other residues from the 
Swedish forest industry. Also, in Brazil second-generation bioetha-
nol production has been established, for example, by Raizen that 
developed a plant in a joint venture with Canadian Iogen, and 
once fully operational it will be producing > 10 million gallons of 
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ethanol annually. Even though these new plants are not yet running 
at full capacity, their operation will eventually result in further refine-
ment and optimization of the processes, and this will pave the way 
for integrating these biomass processing plants with production of 
biofuels other than ethanol.
Outlook
Bio-based production of hydrocarbons provides several attractive 
opportunities for the energy sector: production of molecules with 
improved properties; sustainable production from renewable feed-
stock such as biomass and CO2; reduction in GHG emissions; and 
reduction in particle emission. However, commercial bio-based 
production of hydrocarbons faces three main barriers: high costs 
of developing a cell factory (> US$50 million); difficulties in obtain-
ing cost-competitive production; and high sensitivity to volatile 
oil prices. Overcoming these challenges calls for new scientific 
discoveries, new technology developments and engineering designs. 
Concerning single-carbon feedstock conversion, the efficiency of 
methane activation needs to be improved by orders of magnitude, 
and this requires discovery of novel efficient enzymes and further 
optimization of the metabolic network.
Since biological and chemical processes have different pros and 
cons, combining their advantages could help to develop an econom-
ically viable process for hydrocarbon production100. For example, 
low efficiency enzymes limit alkane production from fatty acids, 
and one may therefore consider producing fatty acids from biomass 
followed by conversion of these to hydrocarbons through chemical 
processes like HEFA.
In summary, current advances in molecular genetics, systems 
biology and synthetic biology can be used for enzyme discovery, 
pathway exploration, biosystems design and construction, which 
will advance microbial cell factory development, and hereby make it 
faster and cheaper to develop efficient bioprocesses for production 
of hydrocarbons to be used as drop-in biofuels. In particular, when 
these production processes are integrated with processes for bio-
mass deconstruction currently being implemented and optimized 
in connection with the development of second-generation ethanol 
production it will become possible to have low-cost production at 
volumes of significance in terms of contributing to reduced GHG 
and particle emissions from trucks and airplanes.
Methods
Calculating theoretical maximum yields. From Table 1, hydrocarbons 
produced by S. cerevisiae were selected to calculate theoretical maximum yields 
using a genome-scale model (GEM). The consensus GEM Yeast 7.6, including 
modifications101, was used to represent the stoichiometry of the S. cerevisiae 
metabolic network, with the following hydrocarbon-specific additions, where 
compartmental localization of metabolites is indicated inside square brackets (c is 
cytosol, p is peroxisome and m is mitochondria). Reactions involving the null sign 
ϕ are sink reactions, whose products are not balanced during flux balance analysis.
Isoprene. As specified previously15, a mitochondrial isoprene synthase reaction was 
added to the GEM, together with an exchange reaction assuming passive transport:
→ +prenyl diphosphate[m] isoprene[m] diphosphate[m]
→ϕisoprene[m]
The mevalonate pathway was localized to the mitochondrion (reactions 
r_0558, r_0667, r_0735, r_0736, r_0737, r_0738, r_0739, r_0904).
Farnesene. As specified previously24, phosphoketolase, phosphotransacetylase, 
acetaldehyde dehydrogenase (acetylating), NADH–HMG reductase and farnesene 
synthase reactions were added to the GEM, together with an exchange reaction 
assuming passive transport:
 −  − + →
 − +  − +
D xylulose 5 phosphate[c] phosphate[c] glyceraldehyde
3 phosphate[c] acetyl phosphate[c] H O[c]2
 − + →  − +acetyl phosphate[c] coenzyme A[c] acetyl CoA[c] phosphate[c]
+ +
→  − + + +
acetaldehyde[c] coenzyme A[c] NAD[c]
acetyl CoA[c] NADH[c] H [c]
− − − − + +
→ − + +
+3 hydroxy 3 methylglutaryl CoA[c] 2H [c] 2NADH[c]
(R) mevalonate[c] coenzyme A[c] 2NAD[c]
→ +farnesyl diphosphate[c] farnesene[c] diphosphate[c]
→ϕfarnesene[c]
Bisabolene. As specified previously26, a cytosolic bisabolene synthase reaction was 
added to the GEM, together with an exchange reaction assuming passive transport:
→ +farnesyl diphosphate[c] bisabolene[c] diphosphate[c]
→ϕbisabolene[c]
Long-chain alkanes. Heptadecane was selected as representative long-chain alkane, 
and as specified previously45, peroxisomal carboxylic acid reductase and aldehyde-
deformylating oxygenase (simplified by removing ferredoxin cycle) reactions were 
added to the GEM, together with an exchange reaction assuming passive transport, 
and a formate diffusion reaction:
+ + →
+ + + + +
stearate[p] NADPH[p] ATP[p] octadecanal[p]
NADP( ) [p] AMP[p] diphosphate[p] H O[p]2
+ + +
→ + + + +
+octadecanal[p] oxygen[p] 2NADPH[p] 2H [p]
heptadecane[p] formate[p] 2NADP( ) [p] H O[p]2
→ϕheptadecane[p]
→formate[p] formate[c]
Long-chain 1-alkenes. 1-Heptadecane was selected as representative long-
chain 1-alkene, and as specified previously46, a cytochrome P450 fatty acid 
decarboxylase was added to the GEM, together with an exchange reaction 
assuming passive transport, and for simplification a reaction generating 
hydrogen peroxide:
+ +
→ − + +
+stearate[c] hydrogen peroxide[c] H [c]
1 heptadecane[c] carbon dioxide[c] 2H O[c]2
− →ϕ1 heptadecane[c]
+ →2H O[c] oxygen[c] 2 hydrogen peroxide[c]2
Flux balance analysis. Non-growth associated maintenance was set to 0, while 
the sole restricting nutrient was glucose with –1 mmol per g DCW per h. Flux 
balance analysis was performed with RAVEN Toolbox102, setting production of the 
hydrocarbon of interest as objective function, resulting in the maximum theoretical 
yields in comparison to reported yields (Fig. 7).
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